These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6531436)

  • 1. Rat brain concentrations of 5-hydroxytryptamine following acute and chronic administration of MAO-inhibiting antidepressants.
    Baker GB; LeGatt DF; Coutts RT; Dewhurst WG
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):653-6. PubMed ID: 6531436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of p-tyramine in rat brain after chronic administration of MAO-inhibiting antidepressants.
    Baker GB; Coutts RT; Legatt DF
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):779-82. PubMed ID: 6686709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain levels of 5-hydroxytryptamine, tryptamine and 2-phenylethylamine in the rat after administration of N-cyanoethyltranylcypromine.
    Baker GB; Nazarali AJ; Coutts RT; Micetich RG; Hall TW
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):657-60. PubMed ID: 6531437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of neurochemical effects of the monoamine oxidase inhibitors phenelzine, moclobemide and brofaromine in the rat after short- and long-term administration.
    Urichuk LJ; Allison K; Holt A; Greenshaw AJ; Baker GB
    J Affect Disord; 2000 May; 58(2):135-44. PubMed ID: 10781703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.
    MacKenzie EM; Grant SL; Baker GB; Wood PL
    Neurochem Res; 2008 Mar; 33(3):430-6. PubMed ID: 17768678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the pharmacological and biochemical properties of substrate-selective monoamine oxidase inhibitors.
    Christmas AJ; Coulson CJ; Maxwell DR; Riddell D
    Br J Pharmacol; 1972 Jul; 45(3):490-503. PubMed ID: 5072232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ring-substituted analogues of tranylcypromine as monoamine oxidase inhibitors.
    Sherry RL; Baker GB; Coutts RT; Mousseau DD
    J Neural Transm Suppl; 1990; 32():107-12. PubMed ID: 1982446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of dihydroxyphenylalanine on the serotonin content of rat brain following pretreatment with monoamine oxidase inhibitors].
    Popov N; Matthies H
    Acta Biol Med Ger; 1966; 17(5):637-43. PubMed ID: 5991588
    [No Abstract]   [Full Text] [Related]  

  • 11. Interactions of a non-selective monoamine oxidase inhibitor, phenelzine, with inhibitors of 5-hydroxytryptamine, dopamine or noradrenaline re-uptake.
    Marley E; Wozniak KM
    J Psychiatr Res; 1984; 18(2):173-89. PubMed ID: 6747915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the MAO inhibitor phenelzine on glutamine and GABA concentrations in rat brain.
    Paslawski TM; Sloley BD; Baker GB
    Prog Brain Res; 1995; 106():181-6. PubMed ID: 8584653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin.
    Todd KG; Baker GB
    J Pharm Pharm Sci; 2008 May; 11(2):14s-21s. PubMed ID: 19203467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical changes in rat brain amines after short- and long-term inhibition of monoamine oxidase by a low dose of tranylcypromine.
    Hampson DR; Baker GB; Coutts RT
    Biol Psychiatry; 1988 Feb; 23(3):227-36. PubMed ID: 3337860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels.
    Griebel G; Curet O; Perrault G; Sanger DJ
    Neuropharmacology; 1998 Jul; 37(7):927-35. PubMed ID: 9776388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system.
    Blier P; De Montigny C; Azzaro AJ
    J Pharmacol Exp Ther; 1986 Jun; 237(3):987-94. PubMed ID: 2423685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional concentrations of cerebral amines: effects of tranylcypromine and phenelzine.
    McKim RH; Calverly DG; Dewhurst WG; Baker GB
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):783-6. PubMed ID: 6141618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Methoxytranylcypromine, a monoamine oxidase inhibitor: effects on biogenic amines in rat brain following chronic administration.
    Sherry-McKenna RL; Baker GB; Mousseau DD; Coutts RT; Dewhurst WG
    Biol Psychiatry; 1992 May; 31(9):881-8. PubMed ID: 1353376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline.
    Todd KG; Baker GB
    J Affect Disord; 1995 Dec; 35(3):125-9. PubMed ID: 8749840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.